DCM Advisors’s Axcelis ACLS Stock Holding History

DCM Advisors’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-28,780	Closed	-$1.16M	–	282
2021 Q2	$1.16M	Buy	28,780 +740	+3%	+$30.7K	0.66%	51
2021 Q1	$1.15M	Buy	28,040 +2,040	+8%	+$76.1K	0.67%	46
2020 Q4	$757K	Buy	+26,000	New	+$673K	0.44%	80

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

DCM Advisors's ACLS Position: Q3 2021 in Review

DCM Advisors sold out of Axcelis (ACLS) in Q3 2021, closing a stake of 28,780 shares — an estimated $1.16M sold.

DCM Advisors first reported a position in ACLS in Q4 2020 and held it in 3 quarters. The position peaked at $1.16M in Q2 2021. 205 funds tracked by Wall St. Rank hold ACLS as of Q3 2021.

DCM Advisors reported no remaining Axcelis position as of Q3 2021 after selling out during the quarter.
DCM Advisors sold 28,780 Axcelis shares in Q3 2021, an estimated $1.16M.
DCM Advisors first reported a position in Axcelis in Q4 2020 and held it in 3 quarters.
DCM Advisors's Axcelis position peaked at $1.16M in Q2 2021.
205 funds tracked by Wall St. Rank held Axcelis as of Q3 2021.

Based on DCM Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.